RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.
Potentiation of Francisella Resistance to Conventional Antibiotics through Small Molecule Adjuvants
Stephens, MD., Hubble, VB., Ernst, RK., van Hoek, ML. M., Cavanagh, J., & Melander C, U. (2016). Potentiation of Francisella Resistance to Conventional Antibiotics through Small Molecule Adjuvants. MedChemComm, 7(1), 128-131. https://doi.org/10.1039/C5MD00353A
A screen of 20 compounds identified small molecule adjuvants capable of potentiating anitbiotic activty against Francisella philomiragia. Analogue synthesis of an initial hit compound led to the discovery of a potentially new class of small molecule adjuvants containg an indole core. The lead compound was able to lower the MIC of colistin by 32-fold against intrinsically resistant F. philomiragia.